Efficacy of Probiotics Supplementation On Chronic Kidney Disease: a Systematic Review and Meta-Analysis

被引:56
|
作者
Jia, Linpei [1 ]
Jia, Qiang [1 ]
Yang, Jingyan [2 ]
Jia, Rufu [2 ]
Zhang, Hongliang [3 ]
机构
[1] Capital Med Univ, Dept Nephrol, Xuanwu Hosp, Beijing, Peoples R China
[2] Cent Hosp Cangzhou, Cangzhou, Peoples R China
[3] Natl Nat Sci Fdn China, Dept Life Sci, Beijing, Peoples R China
来源
KIDNEY & BLOOD PRESSURE RESEARCH | 2018年 / 43卷 / 05期
关键词
Probiotics; Chronic kidney disease; Uremic toxin; Intestinal microbiota; Randomized controlled trial; P-CRESOL; CARDIOVASCULAR RISK; SYNBIOTIC TREATMENT; GUT MICROBIOTA; RENAL-FAILURE; DOUBLE-BLIND; JAK-STAT; HEALTHY; MICROFLORA; CYTOKINE;
D O I
10.1159/000494677
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background/Aims: Dysbiosis of the intestinal microbiota may accelerate the progression of chronic kidney disease (CKD) by increasing the levels of urea toxins. In recent years, probiotics have been recognized to maintain the physiological balance of the intestinal microbiota. In this study, we aim to assess the therapeutic effects of probiotics on CKD patients with and without dialysis via meta-analysis. Methods: We conducted a meta-analysis of randomized controlled trials (RCTs) by searching the databases of Pubmed, EMBASE and Cochrane Library (No. CRD42018093080). Studies on probiotics for treatment of CKD adults lasting for at least 4 weeks were selected. The primary outcomes were the levels of urea toxins, and the second outcomes were the levels of interleukin (IL)-6, C-reactive protein (CRP) and hemoglobin (Hb). The risk of bias was assessed by Cochrane Collaboration' tool, and the quality of evidence was appraised with the Grading of Recommendation Assessment. Means and standard deviations were analyzed by random effects analysis. Stratified analysis was done and sensitivity analysis was performed when appropriate. Results: Totally, eight studies with 261 patients at CKD stage 3 to 5 with and without dialysis were included. We found a decrease of p-cresyl sulfate (PCS) of 3 studies with 125 subjects (P = 0.01, SMD-0.57, 95% CI,-0.99 to-0.14, /2 = 25%) and an increase of IL-6 in 3 studies with 134 subjects (P = 0.03, 95% CI, SMD 0.37, 0.03 to 0.72, /2 = 0%) in the probiotics groups. Analysis of serum creatinine (P = 0.47), blood urine nitrogen (P = 0.73), CRP (P = 0.55) and Hb (P = 0.49) yielded insignificant difference. Conclusion: Limited number of studies and small sample size are limitations of our study. Probiotics supplementation may reduce the levels of PCS and elevate the levels of IL-6 whereby protecting the intestinal epithelial barrier of patients with CKD. (C) 2018 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:1623 / 1635
页数:13
相关论文
共 50 条
  • [41] Prevalence of chronic kidney disease in Bangladesh: a systematic review and meta-analysis
    Banik, Sujan
    Ghosh, Antara
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (04) : 713 - 718
  • [42] Periodontal and chronic kidney disease association: A systematic review and meta-analysis
    Kapellas, Kostas
    Singh, Ankur
    Bertotti, Maite
    Nascimento, Gustavo G.
    Jamieson, Lisa M.
    Hughes, Jaqui
    Sajiv, Cherian
    Fernandes, David
    Pawar, Basant
    Harris, David
    Hoy, Wendy
    Cass, Alan
    Maple-Brown, Louise
    Brown, Alex
    Skilton, Micheal
    Askie, Lisa
    Bartold, P. Mark
    Arrow, Peter
    NEPHROLOGY, 2019, 24 (02) : 202 - 212
  • [43] Ultrasound elastography in chronic kidney disease: a systematic review and meta-analysis
    Ce, Maurizio
    Felisaz, Paolo Florent
    Ali, Marco
    Re Sarto, Giulia Vanessa
    Cellina, Michaela
    JOURNAL OF MEDICAL ULTRASONICS, 2023, 50 (03) : 381 - 415
  • [44] Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis
    Masson, Philip
    Webster, Angela C.
    Hong, Martin
    Turner, Robin
    Lindley, Richard I.
    Craig, Jonathan C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (07) : 1162 - 1169
  • [45] Chemerin levels in chronic kidney disease: A systematic review and meta-analysis
    Behnoush, Amir Hossein
    Shobeiri, Parnian
    Bahiraie, Pegah
    Amirkhani, Nikan
    Khalaji, Amirmohammad
    Peiman, Soheil
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [46] Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis
    Hill, Nathan R.
    Fatoba, Samuel T.
    Oke, Jason L.
    Hirst, Jennifer A.
    O'Callaghan, Christopher A.
    Lasserson, Daniel S.
    Hobbs, F. D. Richard
    PLOS ONE, 2016, 11 (07):
  • [47] Socioeconomic Disparities in Chronic Kidney Disease A Systematic Review and Meta-Analysis
    Vart, Priya
    Gansevoort, Ron T.
    Joosten, Michel M.
    Bultmann, Ute
    Reijneveld, Sijmen A.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2015, 48 (05) : 580 - 592
  • [48] Prevalence of chronic kidney disease in Bangladesh: a systematic review and meta-analysis
    Sujan Banik
    Antara Ghosh
    International Urology and Nephrology, 2021, 53 : 713 - 718
  • [49] Ultrasound elastography in chronic kidney disease: a systematic review and meta-analysis
    Maurizio Cè
    Paolo Florent Felisaz
    Marco Alì
    Giulia Vanessa Re Sartò
    Michaela Cellina
    Journal of Medical Ultrasonics, 2023, 50 : 381 - 415
  • [50] Efficacy of supplementation of probiotics on maternal glycaemic control - A systematic review and meta-analysis of randomized controlled trials
    Ramanathan, Kavitha
    Jagadeesh, Nalini Sirala
    Vishwanath, Usha
    Dayal, Celina
    Chandrababu, Ramesh
    Hayter, Mark
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2021, 10